Article information
Full text is only aviable in PDF
BIBLIOGRAFIA
[1.]
A.J.A. Robalo Cordeiro. Sindrome Asmática Pneumologia Fundamental. pp 283–315.
[2.]
M.J. Abramson, et al.
Evaluation of a new asthma questionnaire.
J Asthma, 28 (1991), pp. 129-139
[3.]
M. Adachi, T. Mita.
Exercise-induced asthma.
pp. 268-291
[4.]
S. Ago.
Allergy and psychosomatic medicine.
Clinical allergy, pp. 146-153
[5.]
American Thoracic Society.
Committee on Diagnostic Standards for Non-Tuberculous Respiratory Diseases Chronic bronchitis, asthma and pulmonary emphysema.
Am Rev Respir Dis, 85 (1962), pp. 762-768
[6.]
Araújo, A. Teles: Asma Ocupacional. In Pneumologia na Prática Clínica. M Freitas e Costa (edit) Vol. 2; pp 233–66.
[7.]
D.I. Bernstein, J.R. Cohn.
Guidelines for the diagnosis and evaluation of occupational immunologic lung disease.
J Allergy Clin Immunol, 84 (1989), pp. 791-793
[8.]
J. Bousquet, et al.
Eosinophilic inflammation in asthma.
N Engl J Med, 323 (1990), pp. 1033-1039
[9.]
M. Branco.
Epitélio Brônquico e Broncomotricidade Monografia do Curso teórico-prático.
Clinica de Doenças Pulmonares, FML, (1991), pp. 38-46
[10.]
A. Bugalho De Almeida.
Alergia.
Imunologia Celular e Inflamação, pp. 29-38
[11.]
A. Bugalho De Almeida.
Mediadores da Inflamação e Obstrução das Vias Aéreas, pp. 41-56
[12.]
P.G.J. Burney, et al.
What symptoms predict the bronchial response to histamine? Evaluation m a community survey of the bronchial symptoms questionnaire (1984) of the International Union Against Tuberculosis and Lung Disease.
Int J Epidemiol, 18 (1989), pp. 165-173
[13.]
B. Burrows, et al.
Association of asthma with serum IgE levels and skin-test reactivity to allergens.
N Engl J Med, 320 (1989), pp. 271-277
[14.]
D.W. Cockcroft, et al.
Determinants of allergen-induced asthma: dose of allergen, circulating IgE antibody concentration, and bronchial responsiveness to inhaled histamine.
Am Rev Respir Dis, 120 (1979), pp. 1053-1058
[15.]
D.W. Cockcroft.
Nonallergic airway responsiveness.
J Allergy Clin Immunol, 81 (1988), pp. 111
[16.]
O.K. Crompton, I.W. Grant, P. Bloomfield.
Edinburgh emergency asthma admission service: report on 10 years' experience.
BMJ, 2 (1979), pp. 1199-1201
[17.]
E. Dariou, C. Perret.
Mechanical controlled hypovenulation in status asthmaticus.
Am Rev Respir Dis, 129 (1984), pp. 385-387
[18.]
L. Dow, D. Coggon, S.T. Holgate.
Respiratory symptoms as predictors of airways lability in an elderly population.
Respir Med, 86 (1992), pp. 27-32
[19.]
L. Dow, et al.
The interaction between immunoglobuin E and smoking in airflow obstruction m the elderly.
Am Rev Respir Dis, 146 (1992), pp. 402-407
[20.]
E. Freitas, M. Costa.
Conceito de Asma Ocupacional Pathos.
Novembro, 84 (1991), pp. 11-14
[21.]
Gonçalyes, J. Rosal.
Clínica e Metodologia Diagnostico das As mas Brônquicas, in Pathos, 78 (1991),
[22.]
Guidelines for the Diagnosis and Management of Bronchial Asthma.
Committee on the Definition, Treatment, and Management of Bronchial Asthma Japanese Society of Allergology.
European Journal of Allergy and Clinical Immunology, 50 (1995),
[23.]
S.M. Harding, S. Freedman.
A comparison of oral and inhaled steroids in patients with chronic airways obstruction features determining response.
Thorax, 33 (1978), pp. 214-218
[24.]
F.E. Hargreave, J. Dolovich, M.T. Newhouse.
The assessment and treatment of asthma·a conference repon.
J Allergy Clin Immunol, 85 (1990), pp. 1098-1111
[25.]
L. Hendeles, M. Weinberger.
Theophylline a "state-of art" review.
Pharmacotherapy, 3 (1983), pp. 2-44
[26.]
International Asthma Management Project (NHLBI, NIH).
International Consensus Report on Diagnosis and Treatment of Asthma.
Clin Exp Allergy, 22 (1992), pp. 1-72
[28.]
P.H. Knapp.
Psychosomatic aspects of bronchial asthma: a review.
pp. 505-564
[29.]
L.A. Laitinen, A. Laitinen, T. Haahtela.
A comparative study of the effects of an inhaled corticosteroid, budesonide, and a β2-agonist, terbutaline, on airway inflamation in newly diagnosed asthma: a randomized, double-blind, parallel-group controlled trial.
J Allergy Clin Immunol, 90 (1992), pp. 32-42
[30.]
S. Lam, et al.
Cellular and protein changes in patients with red cedar asthma.
J Allergy Clin Immunol, 80 (1987), pp. 44-50
[31.]
S. Lam.
Relationship between types of asthmatic reaction, nonspecific bronchial reactivity, and IgE antibodies in patients with red cedar asthma.
J Allergy Clin Immunol, 72 (1983), pp. 134-139
[32.]
E.R. Mcfadden Jr..
Clinical physiologic correlates in asthma: postgraduate course.
J Allergy Clin Immunol, 77 (1986), pp. 1-5
[33.]
T. Miyamoto, et al.
Report of Reassessment Committee for Guidelines for the assessment of severity of bronchial asthma.
Allergy, 43 (1994), pp. 71-80
[34.]
S. Motojima, I. Akutsu, T. Fukuda, et al.
Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma.
Allergy, 48 (1993), pp. 98-106
[35.]
M. Muranaka, K. Nakmima, S. Suzuki.
Bronchial responsiveness to acetylcholine in patients with bronchial asthma after long-term treatment with gold salt.
J Allergy Clin Immunol, 67 (1981), pp. 350-356
[36.]
National Heart, Lung And Blood Institute, National Institutes of Health.
USA International Astma Management Project International Consensus Report on Diagnosis and Treatment of Asthma.
Clin Exp Allergy, 22 (1992),
[37.]
R.M. Nowak, M.C. Tomlanovich, D.D. Sarkar, P.A. Kvale, J.A. Anderson.
Arterial blood gases and pulmonary function testing in acute bronchial asthma: predicting patient outcomes.
JAMA, 249 (1983), pp. 2043-2046
[38.]
B.R. O'Driscoll, R.J. Taylor, M.G. Horsley, D.K. Chambers, A. Bernistein.
Nebulised salbutamol with and without ipratroprium bromide in acute airflow obstruction.
Lancet, I (1989), pp. 1418-1420
[39.]
J.J. Quackenboss, M.D. Lebowitz, M. KrzyzaNowski.
The normal range of diurnal changes in peak expiratory dow rates. Relationship to symptoms and respiratory disease.
Am Rev Respir Dis, 143 (1991), pp. 323-330
[41.]
A.L. Scheffer Chairman.
International consensus report on diagnosis and treatment of asthma.
Clin Exp Allergy, 22 (1992), pp. 39-52
[43.]
M.R. Sears, D.B. Taylor, C.G. Print, et al.
Regular inhaled beta-agonist treatment in bronchial asthma.
Lancet, 336 (1990), pp. 1391-1396
[44.]
A.L. Sheffer, et al.
Guidelines for the diagnosis and management of astma. National Heart Lung, and Blood Institute. National Asthma Education Program Expert Panel Report.
J Allergy Clin Immunol, 88 (1991), pp. 425-534
[45.]
R.G. Slavin, R.E. Cannon, et al.
Sinusitis and bronchial asthma.
J Allergy Clin Immunol, 66 (1980), pp. 250-257
[46.]
R.G. Slavin.
Relationship of nasal disease and sinusitis to bronchial asthma.
Ann Allergy, 49 (1982), pp. 76-80
[47.]
P.D. Sly, et al.
Accuracy of mini peak flow meters in indicating changes in lung function m children with asthma.
Br Med J, 308 (1994), pp. 572-574
[48.]
S.M. Stick, et al.
Bronchial responsiveness and lung function in recurrently wheezy infants.
Am Rev Respir Dis, 144 (1991), pp. 1012-1015
[49.]
T. Takishima, et al.
Direct writing recorder of the dose response curves of the airway to methacholine.
Chest, 61 (1981), pp. 600-606
[50.]
D.R. Taylor, M.R. Sears, G.P. Herbison, et al.
Regular inhaled β2-agonist in asthma: effects on exacerbations and lung function.
Thorax, 48 (1993), pp. 134-138
Copyright © 1997. Sociedade Portuguesa de Pneumologia/SPP
Special content about COVID-19
- Hyperoxemia in invasively ventilated COVID–19 patients–Insights from the PRoVENT–COVID study
- Association between respiratory distress time and invasive mechanical ventilation in COVID-19 patients: A multicentre regional cohort study
- Assisted mobilisation in critical patients with COVID-19
- Two years of COVID-19: Trends in rehabilitation
Open access
This work is licensed under a Creative Commons Attribution 4.0 International License.
Publish in
Pulmonology
Pulmonology
- Home
- All contents
- Publish your article
- About the journal
- Metrics
- Open access
Article options